Moneycontrol

Moneycontrol PRO

you are here: HomeNewsBusinessEarningsBiocon Q1 net seen down 5%, contract research may drive revenue

SHOW NAMES

Trending Topics

business

Biocon Q1 net seen down 5%, contract research may drive revenue

Factors to watch out for in Q1 would be margin, contract research business, R&D cost, pricing pressure in legacy API biz (especially statins), recovery in branded formulation (was flat in Q4 due to restructuring) and pick up in Middle East market (did well in Q4).

first published: Jul 20, 2016 03:34 pm

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347